IGLVI-20: A Protein Involved in Various Cellular Processes (G28769)

Target Name: IGLVI-20

NCBI ID: G28769

IGLVI-20

Other Name(s): IGLVI20 | IGLV(I)-20 | V1-6P | immunoglobulin lambda variable (I)-20 (pseudogene) | Immunoglobulin lambda variable (I)-20 (pseudogene)

IGLVI-20: A Protein Involved in Various Cellular Processes

IGLVI-20, also known as IGLV20, is a protein that is expressed in various tissues of the body, including the brain, lungs, heart, kidneys, and gastrointestinal tract. It is a member of the IGLL family of proteins, which are involved in the regulation of cellular processes such as cell adhesion, migration, and survival.

IGLVI-20 is a 20-kDa protein that is expressed in the brain, where it is involved in the regulation of neuronal excitability and synaptic plasticity. It is thought to play a role in the development and maintenance of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.

IGLVI-20 has also been shown to be involved in the regulation of inflammation and immune responses. It has been shown to play a role in the regulation of T cell responses, which are critical for the immune system's response to infection and disease.

In addition to its role in the immune system, IGLVI-20 is also involved in the regulation of cell survival and proliferation. It has been shown to play a role in the regulation of cell cycle progression, and to promote the G1 checkpoint, which is a critical step in the cell cycle that ensures that cells are able to divide and grow properly.

IGLVI-20 is also involved in the regulation of cell adhesion and migration. It has been shown to play a role in the regulation of cell-cell adhesion, and to contribute to the movement of cells along the surface of the body.

In conclusion, IGLVI-20 is a protein that is involved in a variety of cellular processes that are critical for the development and maintenance of health and function. Its role in the regulation of neuronal excitability, inflammation, and immune responses, as well as its role in cell cycle progression and cell adhesion, make IGLVI-20 an attractive potential drug target. Further research is needed to fully understand the mechanisms of IGLVI-20's function and its potential as a drug.

Protein Name: Immunoglobulin Lambda Variable (I)-20 (pseudogene)

The "IGLVI-20 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGLVI-20 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets